These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10562023)

  • 1. Managing breakthrough cancer pain: a new approach.
    Rhiner M; Kedziera P
    Home Healthc Nurse; 1999 Jun; 17(6 Suppl):suppl 1-12; quiz 13-5. PubMed ID: 10562023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
    Rhiner M; Palos G; Termini M
    Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult cases in pain management: use of methadone in a multifactorial approach.
    Griffie J; Coyne P; Coyle N
    Clin J Oncol Nurs; 2006 Feb; 10(1):45-9. PubMed ID: 16482727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
    Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
    Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing cancer and noncancer chronic pain in critical care settings. Knowledge and skills every nurse needs to know.
    Curtiss CP; Haylock PJ
    Crit Care Nurs Clin North Am; 2001 Jun; 13(2):271-80. PubMed ID: 11866408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors that enable the patients to live their life till death at home by controlling cancer-pains with continuous subcutaneous injection of opioids-case reports of 3 patients with a terminal cancer].
    Yoshimura M; Takeu R
    Gan To Kagaku Ryoho; 2001 Dec; 28 Suppl 1():110-3. PubMed ID: 11787275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated strategies for the successful management of breakthrough cancer pain.
    Dickman A
    Curr Opin Support Palliat Care; 2011 Mar; 5(1):8-14. PubMed ID: 21325998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
    Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.
    Zeppetella G
    J Pain Symptom Manage; 2008 May; 35(5):563-7. PubMed ID: 18258412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the quality of pain treatment by a tailored pain education programme for cancer patients in chronic pain.
    de Wit R; van Dam F; Loonstra S; Zandbelt L; van Buuren A; van der Heijden K; Leenhouts G; Duivenvoorden H; Huijer Abu-Saad H
    Eur J Pain; 2001; 5(3):241-56. PubMed ID: 11558980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-taking tasks and behaviours in Taiwanese outpatients with cancer.
    Liang SY; Yates P; Edwards H; Tsay SL
    J Clin Nurs; 2008 Aug; 17(15):2079-88. PubMed ID: 18705784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study of oncology patients' utilization of breakthrough pain medication.
    Davies AN; Vriens J; Kennett A; McTaggart M
    J Pain Symptom Manage; 2008 Apr; 35(4):406-11. PubMed ID: 18222631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breakthrough pain--analysis and therapy. A pilot study of a new drug, transmucosal fentanyl (Actiq)].
    Johansson H; Arnér S
    Lakartidningen; 2004 Feb; 101(7):552-4. PubMed ID: 15024861
    [No Abstract]   [Full Text] [Related]  

  • 16. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the pain of traumatic injury.
    Alpen MA; Morse C
    Crit Care Nurs Clin North Am; 2001 Jun; 13(2):243-57. PubMed ID: 11866406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids for management of breakthrough pain in cancer patients.
    Potter MB
    Am Fam Physician; 2006 Dec; 74(11):1855-7. PubMed ID: 17168339
    [No Abstract]   [Full Text] [Related]  

  • 19. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.